Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 1,510 | 1,483 | 1,261 | 1,479 | 982 |
| Gross Profit | 1,510 | 1,483 | 1,261 | 1,479 | 982 |
| Operating Expenses | 9,755 | 8,110 | 9,259 | 8,199 | 7,313 |
| Operating Income | -8,245 | -6,627 | -7,998 | -6,720 | -6,331 |
| Other Income | 126 | 144 | 124 | 88 | 84 |
| Pre-tax Income | -8,119 | -6,483 | -7,874 | -6,632 | -6,247 |
| Net Income Continuous | -8,119 | -6,483 | -7,874 | -6,632 | -6,247 |
| Net Income | $-8,119 | $-6,483 | $-7,874 | $-6,632 | $-6,247 |
| EPS Basic Total Ops | -12.25 | -9.50 | -12.00 | -11.75 | -11.75 |
| EPS Basic Continuous Ops | -12.17 | -9.58 | -12.00 | -11.75 | -11.68 |
| EPS Diluted Total Ops | -12.25 | -9.50 | -12.00 | -11.75 | -11.75 |
| EPS Diluted Continuous Ops | -12.17 | -9.58 | -12.00 | -11.75 | -11.68 |
| EBITDA(a) | $-8,189 | $-6,568 | $-7,927 | $-6,627 | $-6,230 |